Is the FDA Really 100 Days Away from Regulating CBD, Delta-8, and Other Hemp Cannabinoids?
Written by on January 5, 2023
It is important to note that the Food and Drug Administration (FDA) has historically had a bias against cannabis and has been slow to recognize the potential therapeutic benefits of the plant. This is likely due to the longstanding federal prohibition on cannabis, which has made it difficult for researchers to study the plant and for the FDA to regulate it as a medicine.